Cargando…

The New Therapeutic Strategies in Pediatric T-Cell Acute Lymphoblastic Leukemia

Childhood acute lymphoblastic leukemia is a genetically heterogeneous cancer that accounts for 10–15% of T-cell acute lymphoblastic leukemia (T-ALL) cases. The T-ALL event-free survival rate (EFS) is 85%. The evaluation of structural and numerical chromosomal changes is important for a comprehensive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lato, Marta Weronika, Przysucha, Anna, Grosman, Sylwia, Zawitkowska, Joanna, Lejman, Monika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123476/ https://www.ncbi.nlm.nih.gov/pubmed/33925883 http://dx.doi.org/10.3390/ijms22094502

Ejemplares similares

Hypodiploidy in a pediatric patient of T-cell acute lymphoblastic leukemia: a case report
por: Stefaniak, Martyna, et al.
Publicado: (2021)

Genomic Analyses of Pediatric Acute Lymphoblastic Leukemia Ph+ and Ph-Like—Recent Progress in Treatment
por: Kaczmarska, Agnieszka, et al.
Publicado: (2021)

Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia—Therapy and Toxicity Mechanisms
por: Lejman, Monika, et al.
Publicado: (2021)

Updates in KMT2A Gene Rearrangement in Pediatric Acute Lymphoblastic Leukemia
por: Górecki, Mateusz, et al.
Publicado: (2023)

Overcoming Steroid Resistance in Pediatric Acute Lymphoblastic Leukemia—The State-of-the-Art Knowledge and Future Prospects
por: Kośmider, Kamil, et al.
Publicado: (2022)

Severe complications in the induction phase of therapy in a pediatric patient with T-cell acute lymphoblastic leukemia: A case report
por: Rocka, Agata, et al.
Publicado: (2023)

Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy
por: Śliwa-Tytko, Patrycja, et al.
Publicado: (2022)

Recent Advances in Treatment Options for Childhood Acute Lymphoblastic Leukemia
por: Malczewska, Marta, et al.
Publicado: (2022)

Overview on Aneuploidy in Childhood B-Cell Acute Lymphoblastic Leukemia
por: Panuciak, Kinga, et al.
Publicado: (2023)

Comprehensive Overview of Gene Rearrangements in Childhood T-Cell Acute Lymphoblastic Leukaemia
por: Mroczek, Anna, et al.
Publicado: (2021)

Diagnostic difficulties of AH1N1 influenza infection in children with acute lymphoblastic leukemia: Two case reports
por: Zawitkowska, Joanna, et al.
Publicado: (2020)

Molecular-Targeted Therapy of Pediatric Acute Myeloid Leukemia
por: Obszański, Piotr, et al.
Publicado: (2022)

Advantages and Limitations of SNP Array in the Molecular Characterization of Pediatric T-Cell Acute Lymphoblastic Leukemia
por: Lejman, Monika, et al.
Publicado: (2020)

Resistance Mechanisms in Pediatric B-Cell Acute Lymphoblastic Leukemia
por: Jędraszek, Krzysztof, et al.
Publicado: (2022)

A Comprehensive Overview of Recent Advances in Epigenetics in Pediatric Acute Lymphoblastic Leukemia
por: Drożak, Paulina, et al.
Publicado: (2022)

First-line treatment failure in childhood acute lymphoblastic leukemia: The polish pediatric leukemia and lymphoma study group experience
por: Zawitkowska, Joanna, et al.
Publicado: (2020)

CAR-T Cells Immunotherapies for the Treatment of Acute Myeloid Leukemia—Recent Advances
por: Zarychta, Julia, et al.
Publicado: (2023)

Editorial: Diagnosis and therapy pediatric hematological malignancies: recent progress
por: Zawitkowska, Joanna, et al.
Publicado: (2023)

The New Treatment Methods for Non-Hodgkin Lymphoma in Pediatric Patients
por: Derebas, Justyna, et al.
Publicado: (2022)

Electrochemical and Optical Sensors for the Detection of Chemical Carcinogens Causing Leukemia
por: Kowalczyk, Adrian, et al.
Publicado: (2023)

The Importance of Selected Dysregulated microRNAs in Diagnosis and Prognosis of Childhood B-Cell Precursor Acute Lymphoblastic Leukemia
por: Ziętara, Karolina Joanna, et al.
Publicado: (2023)

Insights into Modern Therapeutic Approaches in Pediatric Acute Leukemias
por: Panuciak, Kinga, et al.
Publicado: (2022)

Impact of early chimerism status on clinical outcome in children with acute lymphoblastic leukaemia after haematopoietic stem cell transplantation
por: Lejman, Monika, et al.
Publicado: (2019)

The Landscape of Secondary Genetic Rearrangements in Pediatric Patients with B-Cell Acute Lymphoblastic Leukemia with t(12;21)
por: Kaczmarska, Agnieszka, et al.
Publicado: (2023)

Intrachromosomal Amplification of Chromosome 21 in Childhood Acute Lymphoblastic Leukemia: Study of 3 Cases
por: Mroczkowska, Aleksandra, et al.
Publicado: (2021)

MicroRNA as a Prognostic and Diagnostic Marker in T-Cell Acute Lymphoblastic Leukemia
por: Gębarowska, Katarzyna, et al.
Publicado: (2021)

CAR-T Cell Therapy in the Treatment of Pediatric Non-Hodgkin Lymphoma
por: Ostojska, Magdalena, et al.
Publicado: (2023)

Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children
por: Lejman, Monika, et al.
Publicado: (2022)

The Role of TRL7/8 Agonists in Cancer Therapy, with Special Emphasis on Hematologic Malignancies
por: Leśniak, Maria, et al.
Publicado: (2023)

Results of two consecutive treatment protocols in Polish children with acute lymphoblastic leukemia
por: Zawitkowska, Joanna, et al.
Publicado: (2020)

Editorial: Biomarkers and therapeutic strategies in acute lymphoblastic leukemia
por: Lee, Ki-Young, et al.
Publicado: (2023)

Pediatric acute lymphoblastic leukemia
por: Inaba, Hiroto, et al.
Publicado: (2020)

Expression of CD73 on leukemic blasts increases during follow-up – a promising candidate marker for minimal residual disease detection in pediatric B-cell precursor acute lymphoblastic leukemia
por: Słota, Łukasz, et al.
Publicado: (2022)

Multicolor flow cytometry immunophenotyping and characterization of aneuploidy in pediatric B-cell precursor acute lymphoblastic leukemia
por: Pierzyna-Świtała, Magdalena, et al.
Publicado: (2021)

The Use of Inhibitors of Tyrosine Kinase in Paediatric Haemato-Oncology—When and Why?
por: Kaczmarska, Agnieszka, et al.
Publicado: (2021)

Comprehensive chromosomal aberrations in a case of a patient with TCF3-HLF-positive BCP-ALL
por: Lejman, Monika, et al.
Publicado: (2020)

Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia
por: Ogana, Heather A., et al.
Publicado: (2023)

Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia
por: Cani, Alice, et al.
Publicado: (2015)

Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemia
por: Demir, Salih, et al.
Publicado: (2020)

The epigenome in pediatric acute lymphoblastic leukemia: drug resistance and therapeutic opportunities
por: Meyer, Lauren K., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b5ua309nmk17bd4p4aach9g5p3